Ligand Pharmaceuticals: Navigating Market Volatility Amidst Biotech Innovations
Ligand Pharmaceuticals, a biotech company specializing in hormone-activated receptor-targeting drugs, has a market capitalization of $2.21 billion and a stock price of $114.98 as of June 22, 2025.
2 minutes to read